Literature DB >> 29412877

Strengthening Laboratory Management Toward Accreditation, A Model Program for Pathology Laboratory Improvement.

Linda R Andiric1, Lawrence A Chavez1, Mira Johnson1, Kenneth Landgraf1, Danny A Milner2.   

Abstract

The Strengthening Laboratory Management Toward Accreditation (SLMTA) program and subsequent Stepwise Laboratory Quality Improvement Process Toward Accreditation (SLIPTA) checklist were a response to the need for high-quality laboratories to combat the human immunodeficiency virus (HIV) epidemic and provide patients with the highest-quality care. The two tools work together to create a culture of quality in laboratories and allow the identification of gaps. The ultimate goal for any laboratory is to achieve a standard benchmark for quality and these programs have been highly successful in initially affecting the HIV epidemic but continuously improving laboratory quality across all diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  History; Improvement; Laboratory; Quality; SLIPTA; SLMTA; Stepwise; Training

Mesh:

Year:  2017        PMID: 29412877     DOI: 10.1016/j.cll.2017.10.010

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  3 in total

1.  Review of the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) version 2:2015.

Authors:  Tjeerd A M Datema; Linda Oskam; Jacqueline E W Broerse; Paul R Klatser
Journal:  Afr J Lab Med       Date:  2020-10-28

2.  Introduction of quality management in a National Reference Laboratory in Germany.

Authors:  Susanne Homolka; Julia Zallet; Heidi Albert; Anne-Kathrin Witt; Katharina Kranzer
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

3.  Impact of accreditation on health care services performance in Kiryandongo district, Uganda: a longitudinal study.

Authors:  Moses Matovu; Elias Musiime; Patrick Olak; Muhammad Mulindwa; Eve Namisango; Kilian Songwe
Journal:  BMC Health Serv Res       Date:  2022-02-10       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.